- Previous Rank359
- Revenues ($M)8386
- Revenue Percent Change12.2
- Profits ($M)347
- Profits Percent Change
- Assets ($M)18096
- Employees27000
- Market Value — as of March 31, 2017 ($M)34046
Boston Scientific makes medical devices that treat and diagnose medical conditions including heart disease and chronic pain.
Company Info
| CEO | Michael F. Mahoney |
| CEO Title | Chairman, President & Chief Executive Officer |
| Sector | Health Care |
| Industry | Medical Products and Equipment |
| HQ Location | Marlborough, MA |
| Website | www.bostonscientific.com |
| Years on Fortune 500 List | 14 |
| Employees | 27,000 |
Key Financials (Last Fiscal Year)
| Revenues ($M) | $8,386 |
| Profits ($M) | $347 |
| Assets ($M) | $18,096 |
| Total Stockholder Equity ($M) | $6,733 |
| Market Value — as of March 31, 2017 ($M) | $34,046 |
Profit Ratios
| Profit as % of Revenues | 4.1% |
| Profits as % of Assets | 1.9% |
| Profits as % of Stockholder Equity | 5.2% |
Earnings Per Share (Last Fiscal Year)
| Earnings Per Share ($) | 25 |
| EPS % Change (from 2015) | - |
| EPS % Change (5 year annual rate) | -2.9% |
| EPS % Change (10 year annual rate) | - |
Total Return
| Total Return to Investors (2016) | 17.3% |
| Total Return to Investors (5 year, annualized) | 32.3% |
| Total Return to Investors (10 year, annualized) | 2.3% |